Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • March 04 2022

    StageZero Life Sciences Ltd. announced the closing of their Private Placement offering in the amount of CAD $1,870,000. EG&S acted as counsel to the Placement Agent.

  • March 02 2022

    HAVN Life Sciences Inc. announced the closing of their Private Placement offering in the amount of CAD $2,000,000. EG&S acted as counsel to the Placement Agent.

  • March 01 2022

    Ellenoff Grossman & Schole LLP is proud to share our year end accomplishments for 2021 with our clients and colleagues.

    Click here to view our 2021 Year End Review.

  • February 28 2022

    Client Alert: NYC Preps To Lift “Key To NYC” Vaccine Mandate

    Over the weekend, NYC Mayor Eric Adams announced that the Key to NYC program mandating proof of vaccination to enter certain indoor public businesses, including restaurants, bars, gyms and entertainment venues, will likely end Monday, March 7th.

    Click here to read the alert.

  • February 28 2022

    David R. Rothfeld, who leads the Firm’s Traditional Labor Law Practice and is Co-chair of the Firm’s Hospitality Department, was a participant on Cornell’s Center for Innovative Hospitality Labor & Employment Relations Roundtable on Traditional Labor Law held in Delray, Florida on February 25, 2022.

  • February 24 2022

    Delwinds Insurance Acquisition Corp, a special purpose acquisition company, has entered into a definitive merger agreement with FOXO Technologies, Inc.  As a result of the transaction, which values the combined company at an estimated enterprise value of $369 million, FOXO is expected to become publicly listed and plans to trade on the NYSE under ticker symbol ‘FOXO’.  EGS acted as counsel to Delwinds Insurance Acquisition Corp.

  • February 21 2022

    Therma Bright Inc. announced the closing of their Private Placement offering in the amount of CAD $6,000,000. EG&S acted as counsel to the Placement Agent.

  • February 17 2022

    Baudax Bio, Inc. announced the closing of their Underwritten offering in the amount of $10,000,000.  EG&S acted as counsel to the Underwriter.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”